[Edaily Reporter Shin Ha-yeon ] Chabiotech Co.,Ltd.(085660)announced on the 18th that it has decided to acquire 2,524,051 shares of its subsidiary, Cha Healthcare, for 80,316,930,000 won. The acquisition amount represents 7.96% of the company’s equity.
The acquisition will be conducted via an over-the-counter purchase, and the scheduled acquisition date is September 10. Upon completion of the acquisition, Chabiotech Co.,Ltd.’s holdings in Cha Healthcare will increase to 14,168,288 shares, bringing its ownership stake to 60.1%.
The company explained that it decided to purchase Cha Healthcare’s convertible preferred shares after DaishinSecurities-Y2HC New Technology Investment Fund No. 1 and HANWHA INVESTMENT & SECURITIES, both shareholders of Cha Healthcare, exercised their right to demand the purchase of shares.
The acquisition will be conducted via an over-the-counter purchase, and the scheduled acquisition date is September 10. Upon completion of the acquisition, Chabiotech Co.,Ltd.’s holdings in Cha Healthcare will increase to 14,168,288 shares, bringing its ownership stake to 60.1%.
The company explained that it decided to purchase Cha Healthcare’s convertible preferred shares after DaishinSecurities-Y2HC New Technology Investment Fund No. 1 and HANWHA INVESTMENT & SECURITIES, both shareholders of Cha Healthcare, exercised their right to demand the purchase of shares.
